PAA 3.13% 16.5¢ pharmaust limited

"Rugby players face highly increased motor neurone disease risk:...

  1. 1,056 Posts.
    lightbulb Created with Sketch. 2059
    "Rugby players face highly increased motor neurone disease risk: study

    https://japantoday.com/category/features/health/rugby-players-face-highly-increased-mnd-risk-disease-study#:~:text=Rugby%20players%20face%20highly%20increased%20motor%20neurone%20disease%20risk%3A%20study

    Hi all, ( apologies you may have to cut and paste above article) but it's worth a read .

    An extremely influential professional we all know told a good friend of mine MPL will work in MND.

    Last week , I estimated 32 days from onset of treatment to seeing a tangible result in our one patient.

    What is surprising and yet to be appreciated as yet, is calorific control along with MPL which may be of a great synergy to MND.

    Whoever picks us up in round 1 of the draft will have the antithesis of Pandora's box laid on their plate.

    If a big player comes in with a futuristic outlook , imagine the wind fall of what they get. Dog Cancer/ Human Cancer/MND/ HTLV-1 and a plethora of respiratory virus control that is to much to list.

    Which Australian Pharmaceutical Company has the same number of patents as Astrazeneca or Boehringer?

    Which Australian Pharmaceutical Company has more patents than Gilead Science ?

    https://researchbank.swinburne.edu.au/file/0a7ee27f-bef3-4a7c-b32d-87e2c3df372f/1/peter_molloy_thesis.pdf



    This very learned professional elaborates on the value of patents. In fact he is the CEO of the latest start up Biotech Company on the ASX.



 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
16.5¢
Change
0.005(3.13%)
Mkt cap ! $80.22M
Open High Low Value Volume
16.5¢ 17.5¢ 16.5¢ $276.1K 1.636M

Buyers (Bids)

No. Vol. Price($)
4 379426 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 10000 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.